China’s Intelligent Med Device Market Explodes Upscale
This article was originally published in PharmAsia News
As its health operations and patients’ medical data management develop digitally, China’s intelligent medical market is drastically expanding.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.